AGP Executive Report
Last update: 5 hours agoBiotech Deal Shock: Bristol Myers Squibb and Hengrui Pharma just unveiled a blockbuster global alliance worth up to US$15.2B, covering 13 early-stage oncology/hematology/immunology programmes—BMS pays US$600M upfront and more on milestones, with closing expected in Q3 2026. Macao Tourism Push: MGTO targets 3M+ international visitors this year and is betting on broader overseas promotion as Macau’s visitor mix keeps shifting. Gaming Industry Pulse: At G2E Asia + Asian IR Expo in Macau, MGM China CEO Kenneth Feng said suite conversions can lift revenue yields to about 5x regular rooms, while Sands China’s Grant Chum argued Macau’s resort scale remains “impregnable.” IR Talent Pipeline: Galaxy Entertainment Group signed an MOU with Macao University of Tourism to launch the IRISE talent programme. Local Business Moves: Panpuri plans 16 new stores across Asia this year, including a push into Japan first and China later.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
